v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Activities    
Net income $ 247.0 $ 245.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:    
Depreciation, amortization and accretion 37.0 32.0
Provision for credit losses 43.1 34.1
Deferred tax expense (benefit) 8.0 16.0
Loans originated for sale (770.0) (681.0)
Loans sold 720.0 702.0
Net (gains) losses on sale of loans (11.0) (9.0)
Net change in:    
Interest receivable 3.0 (17.0)
Interest payable (5.0) 4.0
Bank owned life insurance, excluding purchases (5.0) (6.0)
Other, net (80.0) 10.0
Net cash flows provided by (used in) operating activities 187.0 330.0
Investing Activities    
Net change in loans and leases, excluding sales and transfers (788.0) (1,449.0)
Debt securities available for sale:    
Purchases (412.0) (725.0)
Maturities/payments 369.0 603.0
Debt securities held to maturity:    
Purchases (297.0) (173.0)
Maturities/payments 166.0 194.0
Increase in premises and equipment (59.0) (59.0)
Net proceeds from sales of portfolio loans 5.0 345.0
Net cash flows provided by (used in) investing activities (1,016.0) (1,264.0)
Financing Activities    
Demand (non-interest-bearing and interest-bearing) and savings accounts 628.0 (389.0)
Time deposits 12.0 670.0
Short-term borrowings 620.0 1,110.0
Proceeds from issuance of long-term borrowings 317.0 271.0
Repayment of long-term borrowings (638.0) (227.0)
Redemption of preferred stock 0.0 (111.0)
Repurchases of common stock (20.0) (3.0)
Cash dividends paid:    
Preferred stock 0.0 (2.0)
Common stock (87.0) (87.0)
Other, net 5.0 6.0
Net cash flows provided by (used in) financing activities 837.0 1,238.0
Net Increase (Decrease) in Cash and Cash Equivalents 8.0 304.0
Cash and cash equivalents at beginning of period 2,419.0 1,576.0
Cash and Cash Equivalents at End of Period $ 2,427.0 $ 1,880.0